A Phase 1/2 Study of NANOVAE for Knee Osteoarthritis
Not Yet Recruiting Phase 1,Phase 2 NCT06606561
Study Description
A Study to Evaluate the Safety and Potential Effectiveness of NANOVAE Injection for Knee Osteoarthritis
Study Details
- Registry ID:
- NCT06606561
- Conditions:
- Knee Osteoarthritis
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 24 participants
- Start Date:
- Age Range:
- 21–75 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Bluetail Medical Group
Chesterfield, Missouri, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.